On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...